Analysing dissatisfaction with a new diffractive trifocal IOL: Rayner RayOne® (original) (raw)
2019, 37th Congress of the European Society Cataract & Refractive Surgeons (ESCRS). Paris, France 🇫🇷
Purpose: A prospective, multi-center, non-randomized clinical study was conducted to determine the visual outcomes as well as patient satisfaction with the Rayner RayOne® diffractive trifocal IOL. Setting: Clinica Baviera, Spain. Baviera Group - AIER Eye Group. Methods: Four hundred and forty-four eyes were enrolled in a prospective, multi-center, non-randomized clinical study to analyze the visual outcomes as well as patient satisfaction with the new Rayner trifocal IOL: the Rayner RayOne®. Patient satisfaction was analyzed using a questionnaire and conducting an in-depth analysis of the electronic medical records. Results were compared to our prior data with regards to Finevision® and ATLisa® trifocal IOLs. Results: Four hundred and forty-four eyes were implanted with the Rayner RayOne® trifocal IOL, and only 1.36% showed dissatisfaction features. Though some patients reported night halos and glare, only two patients reported significant positive dysphotopsia. One patient reported negative dysphotopsia. All patients were spectacle free for all distances. Dissatisfaction features were analyzed and compared to our prior data using Finevision® and ATLisa® trifocal IOLs. Conclusions: The RayOne trifocal IOL provided good visual performance in all distances, though there was a small group of patients who showed dissatisfaction. Having a sounded knowledge of what the reasons for dissatisfaction are might provide us with some key tools to improve patient outcomes.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.